Generic Drugmaker Fabricates Drug Effectiveness Data to Fool FDA
While the focus is usually on name brand , it’s actually the case that 80% of the prescription drugs in the U.S. are generic. Those drugs largely originate from countries outside of the U.S., including India. One of those companies, Ranbaxy, is under fire after a former employee blew the whistle on the generic drugmaker for fabricating drug effectiveness data to get the FDA to allow its products into the U.S.
Ranbaxy Executive Discovers Problem, Other Company Officials Do Nothing
Ranbaxy produces several important generic drugs, including generic Lipitor and …read more